Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
The Female Health Company manufactures markets and sells the Female Condom the only FDA-approved product under a woman\'s control which can prevent unintended pregnancy and sexually transmitted diseases including HIV/AIDS. It is the only HIV/AIDS product specifically developed and approved by regulatory agencies in the U.S. the European Union Japan and The People\'s Republic of China among others since the epidemic beganabout twenty years ago for the prevention of the transmission of HIV/AIDS through sexual contact. Female Health Company has a market cap of $194.3 million; its shares were traded at around $7.1 with a P/E ratio of 30.8 and P/S ratio of 7.5.
Recent Trades of Female Health Company by Directors and Officers:
- Sell: VP and General Manager Michael Pope sold 92,950 shares of FHCO stock on 08/17/2009 at the average price of $6.95; the price of the stock has increased by 2.16% since.
- Sell: VP and General Manager Michael Pope sold 4,959 more shares of FHCO stock on 08/11/2009 at the average price of $6.48; the price of the stock has increased by 9.57% since.
- Sell: VP and General Manager Michael Pope sold 4,959 more shares of FHCO stock on 08/11/2009 at the average price of $6.58; the price of the stock has increased by 7.9% since.
Subscribe RSS
RSS